These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27112488)

  • 1. A seeding based cellular assay of tauopathy.
    Xu Y; Martini-Stoica H; Zheng H
    Mol Neurodegener; 2016 Apr; 11():32. PubMed ID: 27112488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
    Matsumoto G; Matsumoto K; Kimura T; Suhara T; Higuchi M; Sahara N; Mori N
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
    Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
    Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.
    Iba M; Guo JL; McBride JD; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2013 Jan; 33(3):1024-37. PubMed ID: 23325240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.
    Spires-Jones TL; Friedman T; Pitstick R; Polydoro M; Roe A; Carlson GA; Hyman BT
    Neurosci Lett; 2014 Mar; 562():63-8. PubMed ID: 24462887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cargo receptor SQSTM1 ameliorates neurofibrillary tangle pathology and spreading through selective targeting of pathological MAPT (microtubule associated protein tau).
    Xu Y; Zhang S; Zheng H
    Autophagy; 2019 Apr; 15(4):583-598. PubMed ID: 30290707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau oligomers as potential targets for early diagnosis of tauopathy.
    Sahara N; Ren Y; Ward S; Binder LI; Suhara T; Higuchi M
    J Alzheimers Dis; 2014; 40 Suppl 1():S91-6. PubMed ID: 24595194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy.
    Zimova I; Brezovakova V; Hromadka T; Weisova P; Cubinkova V; Valachova B; Filipcik P; Jadhav S; Smolek T; Novak M; Zilka N
    J Alzheimers Dis; 2016 Sep; 54(2):831-43. PubMed ID: 27567836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
    Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
    Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model.
    Cook C; Kang SS; Carlomagno Y; Lin WL; Yue M; Kurti A; Shinohara M; Jansen-West K; Perkerson E; Castanedes-Casey M; Rousseau L; Phillips V; Bu G; Dickson DW; Petrucelli L; Fryer JD
    Hum Mol Genet; 2015 Nov; 24(21):6198-212. PubMed ID: 26276810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
    Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
    PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.
    Peeraer E; Bottelbergs A; Van Kolen K; Stancu IC; Vasconcelos B; Mahieu M; Duytschaever H; Ver Donck L; Torremans A; Sluydts E; Van Acker N; Kemp JA; Mercken M; Brunden KR; Trojanowski JQ; Dewachter I; Lee VM; Moechars D
    Neurobiol Dis; 2015 Jan; 73():83-95. PubMed ID: 25220759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.
    Smolek T; Jadhav S; Brezovakova V; Cubinkova V; Valachova B; Novak P; Zilka N
    Mol Neurobiol; 2019 Jan; 56(1):621-631. PubMed ID: 29770957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
    J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.